Beijing Strong Biotechnologies,Inc. (SHE:300406)
11.85
+0.13 (1.11%)
Sep 1, 2026, 3:04 PM CST
SHE:300406 Market Cap
SHE:300406 has a market cap or net worth of 6.85 billion as of August 31, 2026. Its market cap has decreased by -17.58% in one year.
Market Cap
6.85B
Enterprise Value
7.43B
Revenue
1.37B
Ranking
n/a
PE Ratio
30.92
Stock Price
11.85
ChartMarket Cap Chart
Since October 30, 2014, SHE:300406's market cap has increased from 2.57B to 6.85B, an increase of 167.12%. That is a compound annual growth rate of 8.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 6.85B | -10.33% |
| Dec 31, 2025 | 7.64B | -1.98% |
| Dec 31, 2024 | 7.80B | -30.42% |
| Dec 29, 2023 | 11.21B | 16.60% |
| Dec 30, 2022 | 9.61B | -17.67% |
| Dec 31, 2021 | 11.67B | -20.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Guangzhou Kingmed Diagnostics Group | 12.70B |
| Dian Diagnostics Group | 11.40B |
| Amoy Diagnostics | 6.85B |
| Shanghai Runda Medical Technology | 5.93B |
| Maccura Biotechnology Co.Ltd | 5.64B |
| Cowealth Medical China | 4.93B |
| Shanghai Labway Clinical Laboratory | 4.26B |
| Guangdong Hybribio Biotech | 3.80B |